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NicheWnt signalling is required for hair follicle development and for the growth phase (anagen) of postnatal
follicles. When the pathway is activated at high levels in adult mouse epidermis, ectopic follicles form from
existing follicles, interfollicular epidermis (IFE) and sebaceous glands, revealing a remarkable ability of the
tissue to be reprogrammed. To compare the competence of different epidermal cell populations to form
ectopic follicles, we expressed a 4-hydroxy-tamoxifen (4OHT) inducible, stabilised β-catenin transgene
(ΔNβ-cateninER) under the control of two different promoters. We targeted the reservoir of stem cells in
the hair follicle bulge via the keratin 15 (K15) promoter and targeted the sebaceous glands and base of
the follicle (bulb) with a truncated K5 promoter (ΔK5). No ectopic follicles formed in the IFE in either
model, establishing the autonomy of the IFE stem cell compartment in undamaged epidermis. Activation of
β-catenin in the bulge stimulated proliferation and bulge expansion. Existing hair follicles entered anagen,
but no ectopic follicles formed. ΔK5ΔNβ-cateninER expressing hair follicles also entered anagen on 4OHT
treatment. In addition, a subpopulation of cells at the base of the sebaceous gland readily formed ectopic
follicles, resulting in complete and reversible conversion of sebaceous glands into hair follicles. Combined
activation of β-catenin and the vitamin D receptor enhanced differentiation of sebaceous gland-derived hair
follicles and stimulated ectopic follicle formation in the hair follicle bulb, but not in the bulge. Our results
suggest that the bulge and sebaceous gland are, respectively, non-permissive and permissive niches for Wnt
induced hair follicle differentiation.Institute, Li Ka Shing Centre,
404573.
t).
 license.© 2010 Elsevier Inc. Open access under CC BY license.Introduction
Adult mammalian epidermis is maintained by several distinct
populations of stem cells. They occupy different locations, including
the hair follicle bulge, sebaceous gland, and the junctional zone that
lies between the sebaceous glands, interfollicular epidermis and bulge
(Owens and Watt, 2003; Watt and Jensen, 2009; Fuchs, 2009). Under
normal homeostatic conditions, each stem cell population maintains
only the differentiated lineages appropriate for its location. However,
in response to injury or genetic modiﬁcation, stem cells in any
location are capable of giving rise to progeny that differentiate along
all epidermal lineages (Watt and Jensen, 2009).
One of the key pathways that regulates epidermal lineage
selection is the canonical Wnt pathway (Millar, 2002; Fuchs and
Nowak, 2008). Wnt signalling is required for hair follicle develop-
ment and for the growth phase (anagen) of postnatal follicles. Whenthe pathway is inhibited, hair follicles are no longer maintained, but
convert into cysts of IFE with associated sebocytes (Huelsken et al.,
2001; Merrill et al., 2001; Andl et al., 2002; Niemann et al., 2002).
Conversely, high levels of canonical Wnt activity can induce
formation of ectopic hair follicles. When stabilised, N-terminally
truncated β-catenin (ΔNβ-catenin) is expressed in the epidermis
under the control of the K14 promoter, ectopic follicles form in
homozygous but not in heterozygous animals (Gat et al., 1998; Lowry
et al., 2005).
Ectopic hair follicle formation reﬂects reprogramming of adult
stem cell progeny to select the hair follicle lineages and indicates a
remarkable plasticity of adult epidermis (Silva-Vargas et al., 2005; Ito
et al., 2007; Watt and Collins, 2008). One strategy to examine this
process is to express a 4-hydroxy-tamoxifen (4OHT) inducible β-
catenin transgene (ΔNβ-cateninER) under the control of the K14
promoter (Van Mater et al., 2003; Lo Celso et al., 2004). β-catenin is
selectively activated in adult epidermis by topical application of 4-
hydroxy-tamoxifen (4OHT), and different doses of 4OHT can be used
to achieve different levels of β-catenin activation (Silva-Vargas et al.,
2005).
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interfollicular epidermis (IFE), the hair follicle outer root sheath (ORS)
and at the periphery of the sebaceous gland (SG) (Gat et al., 1998; Lo
Celso et al., 2004). Therefore studies of K14ΔNβ-catenin or K14ΔNβ-
cateninER transgenic mice do not reveal how activation of the
canonical Wnt pathway in one group of cells impacts on ectopic
follicle formation in other regions. Although bulge stem cells
contribute to the normal hair growth cycle it is unknown whether
they are also required for ectopic hair follicle formation (Ito et al.,
2005). Lineage tracing has established that ectopic follicles in the IFE
can arise from IFE cells (Silva-Vargas et al., 2005), but it is unclear
whether some IFE follicles are HF derived. Finally, SG gland-derived
ectopic HF could potentially arise from stem cells in the bulge
(Horsley et al., 2006) or in the junctional zone (Jensen et al., 2009). In
order to investigate these issues, we have expressed the ΔNβ-
cateninER transgene under the control of two different promoters.
We used the K15 promoter to target bulge stem cells (Liu et al., 2003)
and a truncated K5 (ΔK5) promoter to target the HF ORS and SG
(Brown et al., 1998). Unexpectedly, ΔK5 promoter activity was not
detected in the bulge; the construct was primarily expressed in the SG
and HF bulb.
Materials and methods
Transgene construction
The 1320 bp ΔK5 promoter, generously provided by A. Balmain,
UCSF, San Francisco, USA (Brown et al., 1998) was ampliﬁed using
Roche Pwo Superyield DNA Polymerase, with primers containing AvaI
overhangs (5′ CCG GAC TGGGAG CTGGGC TGA G and 3′ TCGGGG TGC
TGG AGA GAA AGA GC). The PCR product was then cleaved using AvaI.
The K14 promoter was excised from an expression cassette kindly
provided by E. Fuchs, The Rockefeller University, New York, USA
(Vasioukhin et al., 1999) using AvaI, its ends dephosphorylated with
calf intestine phosphatase, and the ΔK5 promoter ligated in its place.
The 4968 bp K15 promoter, generously provided by G. Cotsarelis,
University of Pennsylvania, Philadelphia, USA (Liu et al., 2003), was
excised from its expression vector using XmaI and EcoRI, and blunt
ended with mung bean nuclease. The K14 expression cassette, from
which the K14 promoter had been excised, was also blunt ended and
dephosphorylated, before blunt end ligation with the K15 promoter.
To generate the transgene construct, ΔNβ-catenin and ER were
ampliﬁed separately from the T2ER pBabepuro retroviral vector (Lo
Celso et al., 2004) using the following primers: 5′CGG GAT CCA TGG
CAA TCC CCG AGC TGA C and 3′ TAG CTA GCC GCA AGT CAG TGT CAA
ACC (ΔNβ-catenin), 5′ATG CTA GCA CGA AAT GAA ATG AAA TGG GTG
and 3′CGG GAT CCT CAG ATC GTG TTG GGG AAG C (ER). This resulted
in creation of BamHI sites at the 5′ end of ΔNβ-catenin and the 3′ end
of ER and Nhe1 sites at the 3′ end ofΔNβ-catenin and 5′ end of ER. The
PCR products were digested with BamH1 and Nhe1 and ligated into
the K15 and ΔK5 expression cassettes.
A HindIII site in ΔNβ-catenin was removed using the Stratagene
Quikchange XL site-directed mutagenesis kit and primers 5′CTG GTG
GAA TGC AAG CGT TAG GAC TCC ATC TCA C and 3′GTG AGA TGG AGT
CCT AAC GCT TGC ATT CCA CCA G. Each transgene construct was
excised as an EcoRI/HindIII fragment, gel puriﬁed (Qiagen), further
puriﬁed by phenol:chloroform extraction, and then resuspended at a
concentration of 5 µg/ml in sterile injection buffer (10 mM Tris–HCl,
0.1 mM EDTA, pH 7.4) for pronuclear injection.
Generation of transgenic mice and determination of copy number
Each transgene construct was injected into the male pronucleus of
day-1 fertilised (CBA×C57BL/6) F1 embryos. Animals were screened
for the presence of transgene by PCR of ear biopsy DNA with primers
speciﬁc for β-catenin (ATG CTG CTG GCT GGC TAT GGT CAG) and ER(GCA CAC AAA CTC TTC ACC). Founder lines were tested for germline
transmission of each transgene. Transgene copy numbers were
determined using Applied Biosystems 7900HT Fast Real Time PCR
(Ballester et al., 2004).
Data presented are from ΔK5ΔNβ-cateninER line 6470/1.3F (46
copies) and K15ΔNβ-cateninER line 6512.4 (6 copies). ΔK5ΔNβ-
cateninER lines 6577A.2 (2 copies) and 6470/1.20M (8 copies) had a
milder phenotype than line 6470/1.3F. K15ΔNβ-cateninER.6512.2 (6
copies) had a similar phenotype to line 6512.4.Experimental procedures on mice
All experiments were subject to CR-UK ethical review and
performed under the terms of a UK Government Home Ofﬁce licence.
At the start of each experiment mice were 8 weeks old, and therefore
in the resting phase of the hair cycle (Stenn and Paus, 2001). TheΔNβ-
cateninER transgene was activated by topical application of 4-
hydroxy-tamoxifen (4OHT; Sigma). 4OHT was dissolved in acetone
at a concentration of 15 mg/ml. 100 μl was applied per mouse to the
tail and 100 μl to clipped dorsal skin every other day. 4OHT treated
wild type littermates and acetone treated transgenics were used as
controls. No sex-speciﬁc effects of 4OHT were observed.
In some experiments, mice were treated topically with 200 ng (in
100 μl acetone) of the 17-methyl D-ring-1,25-dihydroxyvitamin D3
analogue CD578, 30 min prior to 4OHT treatment. CD578 was a kind
gift from P. DeClerq (University of Gent, Belgium) (Wu et al., 2002).Primary antibodies
Antibodies against the following antigens were used: CCAAT
displacement protein (CDP, Santa Cruz Biotechnology), fatty acid
synthase (IBL), keratin 14 (MK14; rabbit; Covance), keratin 14
(LL002; mouse; Abcam), Lrig1 (goat polyclonal; R & D Systems),
keratin 15 (LHK15; mouse; kind gift of I.M. Leigh), keratin 31 (Progen
Biotechnik), Ki67 (Thermo Scientiﬁc), Lef1 (Upstate), Jagged 1 (Santa
Cruz Biotechnology) and S100A3 (Stratech Scientiﬁc Limited).Histochemistry and immunohistochemistry
Tail epidermal whole mounts were prepared as described
previously (Braun et al., 2003). Tissue samples for sectioning were
either ﬁxed overnight in neutral buffered formalin and embedded in
parafﬁn wax, or, alternatively, frozen, unﬁxed, in OCT compound
(Raymond A. Lamb, UK) on a frozen isopentane surface (cooled with
dry ice). 5 µm sections were prepared and stained with Haematoxylin
and Eosin.
Immunohistochemistry on parafﬁnwax sectionswas performed as
described previously (Niemann et al., 2002). Brieﬂy, antigen retrieval
was performed by boiling in 10 mM sodium citrate buffer (pH 6) for
20 min and non-speciﬁc binding was blocked by incubating the
sections in 10% bovine serum and 3% fetal calf serum for 1 h. Primary
antibodies were diluted in blocking mix, incubated overnight at 4 °C
and detected using ﬂuorescently conjugated secondary antibodies
(Invitrogen).
For immunostaining frozen sections with all antibodies, the
sections were air dried for 5 min, then ﬁxed in 4% paraformaldehyde
(Sigma) for 10 min, permeabilised with 0.1% Triton X-100 (Sigma) for
5 min, blocked for 60 min in 2% BSA (Sigma), 1% milk powder and
0.25% ﬁsh skin gelatin (FSG), then incubated overnight with primary
antibodies.
Ki67 staining was carried out on Leica Bondmax Immunostainer.
Endogenous alkaline phosphatase activity was visualised in frozen
sections using the Sigma Alkaline Phosphatase Leukocyte kit, with
FRV-alkaline solution (red), and counterstained with haemotoxylin.
Fig. 1. Sites of transgene expression. (A) Schematic of the ΔK5 and K15ΔNβ-cateninER
constructs. Double headed arrow indicates region detected with the in situ hybridisa-
tion probe. (B) Schematic showing sites of promoter activity. The ΔK5 promoter targets
the hair follicle bulb (HB) and sebaceous glands (SG) but not the bulge (BG). The K15
promoter targets the hair follicle bulge. Neither promoter is active in the interfollicular
epidermis (IFE) or infundibulum (INF). (C–F) In situ hybridisation of back skin sections
of K15ΔNβ-cateninER (K15) and ΔK5ΔNβ-cateninER (ΔK5) transgenic mouse lines
treated with 4OHT for (C, D) 1 day or (E, F) 21 days. Arrowheads indicate position of
bulge; arrowsmark hair bulb and sebaceous glands. Silver grains in darkﬁeld images are
false coloured red, superimposed on haemotoxylin staining. Scale bars: 50 µm.
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microscope. All H&E and alkaline phosphatase stained sections were
scanned using a Scanscope XT (Aperio).
In situ hybridisation
In situ hybridisation was performed as described previously
(Poulsom et al., 1998), using 35S-labeled riboprobes to ΔNβ-
cateninER. The ΔNβ-cateninER probe was generated by digesting
the transgene construct with Pst1, and inserting the resultant 760 bp
DNA fragment into pgem3z vector. Hybridisation with a β-actin
antisense probe served as a positive control. In situ images were
photographed with an Olympus BX51 microscope and colour
switched to red in Adobe Photoshop to distinguish the positive signal
from black pigmentation in melanocytes.
Results
The K15 and ΔK5 promoters target the ΔNβ-cateninER transgene to
different epidermal locations
The transgene cassettes used in this study and their reported sites
of expression are shown schematically in Figs. 1A, B. Multiple
independent transgenic lines were generated for each construct and
gave similar phenotypes, thereby ruling out effects of integration site.
The sites of transgene expression were conﬁrmed by radioactive in
situ hybridisation using a probe spanning the boundary between the
β-catenin C-terminus and the estrogen receptor (ER) (Figs. 1A, C–F)
and by immunolabelling the epidermis with antibodies to the ER
epitope (Silva-Vargas et al., 2005; data not shown).
As expected from previous studies (Liu et al., 2003), the K15
promoter was only active in the HF bulge, a well-characterized
reservoir of quiescent stem cells that express K15, CD34 and a range of
othermarkers (Figs. 1B, C, E; Trempus et al., 2003; Tumbar et al., 2004;
Cotsarelis, 2006; Watt and Jensen, 2009). Promoter activity was
restricted to the bulge, both in untreated transgenic mice and when
the skin was treated with 4OHT to activate the β-catenin transgene
(Figs. 1C, E and data not shown).
In adult mice, the ΔK5 promoter is known to be active almost
exclusively in the hair follicle (Brown et al., 1998). Consistent with
this, we did not observe expression in the IFE or infundibulum, which
connects the hair follicle with the IFE. ΔK5ΔNβ-cateninER was
expressed at the periphery of the SG, along the ORS and in the hair
follicle bulb (Figs. 1B, D). We did not detect expression in the bulge,
even though bulge stem cells express keratin 5 (Fig. 1D, arrowheads).
Following 4OHT treatment the transgene continued to be expressed in
existing and ectopic hair follicles but not in the IFE (Fig. 1F).
β-catenin activation induces expression of known Wnt target genes
In order to conﬁrm that β-catenin signalling was active in both
transgenic models, back skin was treated for up to 21 days with 4OHT
and then stained with antibodies to β-catenin (Fig. 2). In wild type
epidermis, most β-catenin was localized at cell–cell borders; the
only site of active canonical Wnt signalling, as indicated by nuclear
β-catenin, was in the bulb of anagen follicles (Gat et al., 1998; Lo
Celso et al., 2004; Figs. 2A, F and data not shown). In 4OHT treated
K15ΔNβ-cateninER epidermis nuclearβ-cateninwas detected in cells in
the bulge (Figs. 2B, C), whereas in ΔK5ΔNβ-cateninER epidermis the
most prominent site of nuclearβ-cateninwas in cells at the periphery of
the SG (Figs. 2D–E).
As further conﬁrmation of the sites of Wnt signalling activity, back
skin was treated for 21 days with 4OHT and then labeled with
antibodies to Lef1 and Jagged1, two well-characterized β-catenin
target genes (Filali et al., 2002; Estrach et al., 2006) (Fig. 3). As
reported previously (Huelsken et al., 2001; Merrill et al., 2001;Niemann et al., 2002; Jamora et al., 2003; Estrach et al., 2006; Nowak
et al., 2008), in wild type skin Lef1 and Jagged1 were expressed most
abundantly in the bulb of anagen follicles, where endogenous Wnt
signalling is most active (data not shown). In K15ΔNβ-cateninER
transgenic skin there was upregulation of Lef1 (Figs. 3A, C) and
Jagged1 (Figs. 3E, G) in the bulge. In ΔK5ΔNβ-cateninER transgenic
skin Jagged1 and Lef1 were upregulated in the sebaceous gland and
HF bulb (Figs. 3B, D, F, H). We conclude that targets of the canonical
Wnt pathway are activated in those cells that express the β-catenin
transgene under the control of the K15 or ΔK5 promoter.
Fig. 2. Location of cells with nuclear β-catenin. Sections of wild type telogen back skin (A) or transgenic back skin that had received repeated 4OHT applications for the number of
weeks shown (B–F) were labeled with antibodies to keratin 14 (green) and β-catenin (red) and counterstained with DAPI (blue). Boxed regions in B, D are shown at higher
magniﬁcation in C, E, respectively. Arrows indicate β-catenin positive nuclei. (F) Nuclear β-catenin in cells at the base of an anagen follicle. Scale bar: 100 µm.
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gland and outer root sheath
A single application of 4OHT is sufﬁcient to drive hair follicles into
anagen in K14ΔNβ-cateninER transgenicmice (VanMater et al., 2003;
Lo Celso et al., 2004). However, the speciﬁc cells that are involvedFig. 3. Expression of β-catenin target genes Lef1 and Jagged1. Immunoﬂuorescence labeling o
with 4OHT for 21 days. Antibodies detected (A–D) Lef1 (red), (E–H) Jagged1 (red). Sections
visualise nuclei. Boxed regions in A, B, E, F are shown at higher magniﬁcation in C, D, G, H,have not been deﬁned. To examine this, we treated transgenic mice in
the resting (telogen) phase of the hair cyclewith a single dose of 4OHT
and monitored the effects on the epidermis for up to three weeks
(Fig. 4). 4OHT treated wild type mice and transgenic mice treated
with vehicle (acetone) alone did not enter anagen during this period
(Figs. 4A, B and data not shown). We observed that hair follicles inf sections of K15ΔNβ-cateninER (K15) and ΔK5ΔNβ-cateninER (ΔK5) back skin treated
were also labeled with anti-keratin 14 (green) and counterstained with DAPI (blue) to
respectively. Scale bars: 50 µm.
Fig. 4. Effects of a single dose of 4OHT. Haematoxylin and eosin stained sections of back skin from telogen mice that had been treated once with acetone (B) or 4OHT (A, C–H) and
collected 1–3 weeks later. WT: wild type. Arrows show anagen follicles. Asterisks show ectopic follicles. Scale bar: 100 µm.
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begun to enter anagen 1 week after 4OHT treatment (Figs. 4C, D),
and by 2 weeks the majority of follicles were in full anagen (arrows,
Figs. 4E, F). At 2 weeks ectopic follicles arising from the SG were
observed in ΔK5ΔNβ-cateninER mice (Fig. 4F, asterisks); however, no
ectopic follicles were observed in K15ΔNβ-cateninER mice (Fig. 4E).
By 3 weeks after 4OHT treatment both K15ΔNβ-cateninER and
ΔK5ΔNβ-cateninER epidermis had re-entered telogen. We conclude
that expression of β-catenin under the control of either the K15 or the
ΔK5 promoter is sufﬁcient to drive anagen, indicating that there is no
absolute requirement for direct activation of bulge stem cells.
In order to examine ectopic follicle formation in more detail we
next investigated the effects of repeated applications of 4OHT. Back
skin was treated for up to three weeks, starting when the mice were
8 weeks old and in the telogen phase of the hair growth cycle
(Figs. 5A–L). Wild type mice remained in telogen throughout the
4OHT treatment period and for three weeks after treatment had
ceased (Figs. 5A–D). In contrast, K15ΔNβ-cateninER and ΔK5ΔNβ-
cateninER transgenic mouse skin entered anagen within 7 days of
treatment (Figs. 5E, I). When the skin was analysed 21 days after
4OHT treatment had ended, K15ΔNβ-cateninER follicles were exitinganagen (Fig. 5H), while anagen persisted in ΔK5ΔNβ-cateninER skin
(Fig. 5L).
In K15ΔNβ-cateninER mice no ectopic follicles formed, the only
effect of β-catenin activation, in addition to anagen induction, being
swelling of the bulge from 14 days onwards (Figs. 5F, G, P). Once 4OHT
treatment stopped the bulge returned to its normal size (Fig. 5H). In
contrast, ectopic follicles were readily visible from 14 days in ΔK5ΔNβ-
cateninERmice andbecameprogressively enlarged andmoremature by
21 days (Figs. 5J, K). As in the case of K14ΔNβ-cateninERmice (Lo Celso
et al., 2004), ectopic follicles regressed partially but not completely
when 4OHT treatment was stopped (Fig. 5L).
In tail skin, as in back, anagen was induced by activation of either
transgene (Figs. 5M, N; data not shown). In K15ΔNβ-cateninER
transgenic epidermis swelling of the bulge was observed (data not
shown). However, as in back skin, ectopic follicles only developed
when the transgene was expressed under the control of the ΔK5
promoter (Fig. 5N). In tail skin some ΔK5ΔNβ-cateninER transgenic
mice developed large cysts, which were not observed in back skin and
persisted after 4OHT treatment had stopped (Figs. 5N, O).
In ΔK5ΔNβ-cateninER mice, ectopic follicles formed from the SG
and ORS but not from the IFE or bulge (Figs. 5J, K). To quantitate
Fig. 5. Effects of repeated doses of 4OHT. Haematoxylin and eosin stained sections of wild type (WT), K15ΔNβ-cateninER (K15) and ΔK5ΔNβ-cateninER (ΔK5) transgenic skin
treated with 4OHT for 7 days (A, E, I, Q, R), 14 days (B, F, J, S), 21 days (C, G, K, M, N, P), or 21 days + 21 days recovery (D, H, L, O). Note cysts in (N, O) and conversion of sebaceous
glands into ectopic hair follicles in (Q–S). Scale bars: 50 µm.
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that had been treated with 4OHT for 21 days were immunolabelled
with antibodies to CDP, which is expressed in ectopic follicles (Lo
Celso et al., 2004; Silva-Vargas et al., 2005). For 100 pre-existing HF,
examined in sections of back skin from three different mice, we scored
the number of CDP positive outgrowths from SG, ORS and hair follicle
bulb (HB), all sites in which the promoter is active (Figs. 1–3). No
ectopic follicles were detected emanating from the bulb (Table 1). 5%
of ectopic follicles arose from the ORS, but the overwhelmingmajority
of ectopic follicles arose from the SG (Table 1). Within the SG, ectopic
follicles arose from a small group of undifferentiated cells in the lower
SG that lacked expression of the junctional zone stem cell marker
Lrig1 (Figs. 5Q–S and data not shown; Jensen et al., 2009).
The different phenotypes of K15ΔNβ-cateninER and ΔK5ΔNβ-
cateninER transgenic mice did not reﬂect differences in the prolifer-
ative response to β-catenin (Fig. 6). Ki67 labeling revealed extensive
proliferation at the base of anagen follicles in both models (Figs. 6B, C,Table 1
Quantitation of ectopic hair follicle formation in ΔK5ΔNβ-cateninER epidermis treated
with 4OHT alone or in combination with vitamin D analogue (Vit D). EF: ectopic
follicles; SG: sebaceous gland; ORS: outer root sheath; HB: hair bulb.
Condition No. hair follicles
scored
Total EF EF from
SG
EF in ORS EF from
HB
4OHT only 100 148 141 (95%) 7 (5%) 0 (0%)
4OHT+Vit D 95 261 138 (53%) 115 (44%) 8 (3%)E, F). In K15ΔNβ-cateninER transgenics there was extensive prolifer-
ation of bulge cells (Figs. 6B, E), while in ΔK5ΔNβ-cateninER
transgenics there was proliferation associated with areas of develop-
ing ectopic follicles (Figs. 6C, F).
Expression of markers of HF, SG and IFE
To characterize the changes induced by β-catenin activation, we
examined expression of a range of lineage markers. Keratin 10,
ﬁlaggrin and loricrin were used as markers of IFE (data not shown;
Niemann et al., 2002). CCAAT displacement protein (CDP) is
expressed in early ectopic follicles and in the inner root sheath and
companion layer of mature follicles (Figs. 7A–C, F; Silva-Vargas et al.,
2005). S100A3 (Figs. 7D, E) and K31 (hHa1) (Figs. 7G–I) were
examined as markers of the cuticle and cortical layers of the hair
follicle, respectively (Pálmer et al., 2008a). Fatty acid synthase and the
lipophilic dye Nile Red were examined as markers of mature
sebocytes (Fig. 8 and data not shown; Lo Celso et al., 2004; Berta
et al., 2009).
The only lineage marker to be expressed in the enlarged bulge of
K15ΔNβ-cateninER follicles was CDP (Figs. 7A, B, D, G and data not
shown). CDP was widely expressed in ectopic follicles in ΔK5ΔNβ-
cateninER skin (Figs. 7C, F), while K31 and S100A3 were expressed in
a subset of ectopic follicles (Figs. 7E, H, I). Ectopic ΔK5ΔNβ-cateninER
follicles did not express K10 (data not shown).
Fatty acid synthase was highly expressed in all sebaceous glands of
wild type and untreated transgenic epidermis (Fig. 8A and data not
shown). In contrast, expression of fatty acid synthase was almost
Fig. 6. Activation of β-catenin stimulates proliferation in transgene positive epidermal
cells. Immunohistochemical labeling with anti-Ki67 (brown) of back and tail skin from
wild type (WT) (A, D), K15ΔNβ-cateninER (K15) (B, E) and ΔK5ΔNβ-cateninER (ΔK5)
(C, F) transgenic mice following treatment with 4OHT for 21 days. Scale bars: 50 µm.
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mice, correlating with the conversion of essentially all SG into hair
follicles (Fig. 8B, arrows; Fig. 5J). The few areas of fatty acid synthase
expression that remainedwere in residual SG (Fig. 8B, asterisk).When
mice were treated with 4OHT for 21 days and examined 21 days later,
ectopic follicles had largely regressed (Fig. 5L); SGs had reformed and
were fatty acid synthase positive (Fig. 8C, asterisks). The cysts that
formed in tail epidermis of ΔK5ΔNβ-cateninER mice labeled positive
for Nile Red, fatty acid synthase, CDP and occasionally K31, but not for
K10 (Fig. 8D and data not shown) and thus exhibited elements of both
sebocyte and HF differentiation.
We conclude that β-catenin activation does not induce expression
of markers of mature SG, IFE or HF lineages in the bulge. β-catenin
activation in the SG results in a switch from SG differentiation to HF
differentiation. In the tail a subset of SG retain their differentiated
characteristics, while also expressing HF markers and these have the
morphological appearance of cysts. This contrasts with the mixed IFE
and SG lineages in cysts that form on overexpression of N-terminally
truncated dominant negative Lef1 (Niemann et al., 2002).
Expression of bulge and junctional zone stem cell markers
Multiple pools of stem cells have now been identiﬁed in different
regions of the epidermis, including the bulge of the hair follicle and
the junctional zone that lies between the hair follicles, sebaceous
glands and infundibulum of the interfollicular epidermis (reviewed by
Watt and Jensen, 2009). It was previously reported that β-catenin-
induced ectopic hair follicle formation does not affect expression ofthe bulge marker K15 in existing hair follicles (Silva-Vargas et al.,
2005). In contrast, β-catenin activation increases the size of the
junctional zone stem cell compartment, and loss of Lrig1, which is
normally highly expressed in the junctional zone, causes a selective
increase in β-catenin-induced ectopic hair follicle formation in the
interfollicular epidermis (Jensen et al., 2009). These observations led
us to investigate whether selective β-catenin activation in the bulge or
SG and hair follicle bulb affected expression of K15 and Lrig1 (Fig. 9).
We examined K15 expression in whole mounts of tail epidermis
(Braun et al., 2003) and in conventional sections of back skin
(Figs. 9A–C and data not shown). 4OHT treatment of K15ΔNβ-
cateninER or ΔK5ΔNβ-cateninER back or tail skin did not cause any
change in K15 expression in the hair follicle bulge (Figs. 9A–C and data
not shown). In contrast, 4OHT treatment of K15ΔNβ-cateninER skin
resulted in increased Lrig1 expression in the infundibulum (Figs. 9D, E).
4OHT treatment of ΔK5ΔNβ-cateninER back skin also led to increased
Lrig1 expression; however, in this case expression not only extended
upwards into the infundibulum, but also downwards along the ORS of
anagen follicles and into ectopic follicles (Fig. 9F). Thus, β-catenin
activation does not affect expression of K15 within existing follicles but
results in upregulation of Lrig1, regardless of which promoter is used to
drive transgene expression.
Vitamin D treatment stimulates differentiation of the HF lineages
It has previously been reported that one third of epidermalβ-catenin
target genes lack Lef/Tcf sites but contain vitamin D response elements,
and are regulated by direct interactions between β-catenin and the
vitamin D receptor (Cianferotti et al., 2007; Pálmer et al., 2008a).
Combined treatment of K14ΔNβ-cateninER mice with 4OHT and an
analogue of the active form of vitamin D (1,25-dihydroxyvitamin D3)
promotes ectopic hair follicle differentiation to a greater extent than
treatment with 4OHT alone (Pálmer et al., 2008a). We therefore
examined whether treatment with a 1,25-dihydroxyvitamin D3
analogue (CD578; Wu et al., 2002) would alter the phenotype of
K15ΔNβ-cateninER and ΔK5ΔNβ-cateninER mice.
CD578 treatment of wild type and transgenic skin led to a
thickening of the IFE but did not affect the SG and HF (Fig. 10B and
data not shown). Combined treatment of K15ΔNβ-cateninER mice
with 4OHT and the 1,25-dihydroxyvitamin D3 analogue led to a
reduction in Ki67 labeling in the bulge, but otherwise had no
discernible effect compared to 4OHT treatment alone (data not
shown). In contrast, ΔK5ΔNβ-cateninER mice showed a profoundly
different phenotype when treated with both 4OHT and CD578
(Fig. 10C) as opposed to 4OHT alone (Fig. 10A). In the presence of
the 1,25-dihydroxyvitamin D3 analogue proliferation of ectopic
follicles was decreased (Fig. 10D; compare Fig. 6C) and the follicles
arising from the SG formed mature, alkaline phosphatase-positive
dermal papillae that were encircled by the adjacent epithelium
(Figs. 10E, F, H, J; Lo Celso et al., 2004; Handjiski et al., 1994). HF
differentiation was stimulated, as judged by increased expression of
K31 (Fig. 10K), S100A3 (Fig. 10L), and the appearance of mature hair
shafts (Fig. 10C). In addition, 1,25-dihydroxyvitamin D3 treatment led
to an increase in the number of ectopic follicles arising out of the ORS
and bulb (Table 1); this is illustrated in Fig. 10I, which shows a hair
bulb with two ectopic CDP positive outgrowths. We conclude that
concomitant activation of β-catenin and the vitamin D receptor
promotes hair follicle differentiation at the expense of proliferation.
Discussion
In order to compare the sensitivity of different adult epidermal
subpopulations to β-catenin activation, we targeted a 4-hydroxy-
tamoxifen (4OHT) inducible, stabilised β-catenin transgene to the hair
follicle bulge (K15ΔNβ-cateninER) or to the outer root sheath and
sebaceous glands (ΔK5ΔNβ-cateninER). Activation of either transgene
Fig. 7. Expression of hair follicle differentiation markers. Immunoﬂuorescence staining of K15ΔNβ-cateninER (K15) and ΔK5ΔNβ-cateninER (ΔK5) transgenic back skin following
21 days of 4OHT treatment. Sections were labeled with antibodies to (A–C, F) CDP (red), (D, E) S100A3 (red) or (G–I) K31 (red), and keratin 14 (green), with DAPI nuclear
counterstain (blue). Scale bars: 50 µm.
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differentiation. The lack of ectopic follicles in the interfollicular epi-
dermis is consistent with our earlier observation (Silva-Vargas et al.,
2005) that ectopic follicles induced in the IFE byβ-catenin activation are
derived from IFE cells, not from migration of cells from the HF, as
subsequently conﬁrmed by others (Ito et al., 2007).
While it is well established that Wnt signalling is required to
initiate anagen (DasGupta and Fuchs, 1999; Van Mater et al., 2003; Lo
Celso et al., 2004; Lowry et al., 2005), our experiments are the ﬁrst to
show that activation of β-catenin exclusively in the bulge is sufﬁcient
to drive anagen. It is more surprising that activation of β-catenin in
cells expressing the ΔK5 promoter triggered anagen, since the ΔK5
promoter was not active in the bulge: no ΔK5-driven transgene
expression was detected by in situ hybridisation or antibody staining;
transgene activation did not stimulate bulge cells to proliferate; and
there was no induction of CDP, Lef1 or Jagged1 in the bulge ofΔK5ΔNβ-
cateninER follicles.There are a number of possible explanations for how non-bulge
hair follicle cells could drive anagen. First, β-catenin activation could
induce conversion into hair follicle stem cells; one precedent for that
is β-catenin mediated induction of IFE cells to express bulge stem cell
markers such as CD34 (Silva-Vargas et al., 2005). The β-catenin
responsive cells would not necessarily be stem cells themselves, given
that committed IFE progenitors can exhibit multi-lineage differenti-
ation potential in epidermal reconstitution assays (Jensen et al.,
2009). Secondly, the cells driving anagen could be a distinct, pre-
existing stem cell population; in support of this, a growing number of
stem cell populations outside the bulge have now been described
(Watt and Jensen, 2009; Snippert et al., 2010) and there has long been
evidence for the existence of a distinct population of stem cells in the
germinative compartment of the secondary hair germ (Panteleyev
et al., 2001). Finally, cells are known to move downwards from the
bulge during normal anagen (Braun et al., 2003; Tumbar et al., 2004;
Jaks et al., 2008) and β-catenin mediated stimulation of proliferation
Fig. 8. Sebaceous gland differentiation. Immunoﬂuorescence staining of wild type (WT) and ΔK5ΔNβ-cateninER (ΔK5) transgenic back (A–C) and tail (D) skin following 21 days of
4OHT treatment. Skin in (C) was left untreated for a further 21 days. Sections were labeled with antibodies fatty acid synthase (red) and keratin 14 (green), with DAPI nuclear
counterstain (blue). Asterisks indicate fatty acid synthase positive regions. Arrows in (B) indicate ectopic HF arising from SG. Arrows in (D) indicate cysts. Scale bar: 50 µm.
Fig. 9. Expression of stem cell markers K15 and Lrig1. Immunoﬂuorescence staining of wild type (WT), K15ΔNβ-cateninER (K15) and ΔK5ΔNβ-cateninER (ΔK5) transgenic skin
following 21 days of 4OHT treatment. (A–C) Tail skin whole mounts labeled for K15 (red) and K14 (green) with DAPI nuclear counterstain (blue). Brackets indicate position of bulge
in existing follicles. (D–F) Back skin sections labeled with anti-Lrig1 (red) with DAPI nuclear counterstain (blue). Scale bar: 50 µm.
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Fig. 10. Effects of combined activation of β-catenin and vitamin D receptor. Back skin of
ΔK5ΔNβ-cateninER transgenic mice was treated with (A) 4OHT alone, (B) 1,25-
dihydroxyvitamin D3 analogue alone (Vit D) or (C–L) 4OHT and 1,25-dihydroxyvitamin
D3 analogue for 14 days. (A–C) H&E stained sections. (D) Ki67 immunohistochemical
staining. (E, F) Histochemical detection of alkaline phosphatase activity (red). (G–L)
Immunoﬂuorescence staining of (G–I) CDP (red), (J) (α8 integrin (red), (K) K31 (red),
(L) S100A3 (red) and keratin 14 (green), with DAPI nuclear counterstain (blue). Scale
bars: 50 µm.
49C.M. Baker et al. / Developmental Biology 343 (2010) 40–50and downgrowth of the follicle bulb could stimulate replenishment by
hair follicle bulge cells (Greco et al., 2009).
The most striking difference between 4OHT treated ΔK5ΔNβ-
cateninER and K15ΔNβ-cateninER skin was that only the ΔK5
promoter triggered ectopic follicle formation. Activation of β-catenin
in the bulge failed to induce ectopic follicles, even though Lef1 and
Jagged1 were upregulated and proliferation was stimulated, and
expression of the bulge marker K15, which is expressed both by
quiescent and actively cycling (Lgr5-positive) bulge stem cells (Watt
and Jensen, 2009), was unaffected. Our ﬁndings ﬁt well with the
observation that ablation of expression of BMP receptor 1a causes
expansion of the bulge, proliferation and upregulation of Lef1 and β-
catenin signalling, yet does not induce ectopic follicles (Zhang et al.,
2006; Kobielak et al., 2007).
The bulge differs from the rest of the epidermis in expressing Tcf3
and 4, which are required for hair follicle maintenance (Merrill et al.,
2001; Nguyen et al., 2009) and therefore the set of genes activated by
ß-catenin in the bulge will differ from those in the SG and ORS.
Expression of the Notch ligand Jagged1 is required for ectopic follicle
formation (Estrach et al., 2006) and Jagged1 was only weakly
upregulated in the bulge of K15ΔNβ-cateninER hair follicles. Howev-
er, this cannot account for the lack of ectopic follicles, because whenwe examined the epidermis of mice in which both β-catenin and
Notch were activated we only found very occasional outgrowths from
the bulge (Estrach et al., 2006; Baker and Watt, unpublished).
Another likely explanation for the lack of ectopic follicles
originating in the bulge is that the local microenvironment is not
permissive for differentiation. The bulge microenvironment has
several unique characteristics, both in terms of expression of adhesion
molecules and in terms of the proximity of non-epidermal cells, such
as melanocyte stem cells and immature Langerhans cells (Cotsarelis,
2006). The adhesive properties of the bulge may ensure that cells
exiting the bulge move downwards, except following wounding or
during tumour initiation (Ito et al., 2005, 2007; Malanchi et al., 2008).
For example, the intercellular adhesion protein Nectin-likemolecule 2
(Necl2) contributes to bulge cell adhesion and not only promotes
stem cell quiescence but also restricts cell motility (Giangreco et al.,
2009). The progeny of K15ΔNβ-cateninER positive cells that exit the
bulge no longer express the transgene and so are unable to form
ectopic follicles in the ORS or bulb.
In contrast to the bulge, the base of the SG is a highly permissive
environment for ectopic follicle formation and follicles were induced
in that location after a single dose of 4OHT. 4OHT treatment of
ΔK5ΔNβ-cateninER skin led to proliferation of cells in the SG. As
ectopic follicle formation proceeded, all differentiated sebocytes were
lost from the SG; however, on withdrawal of 4OHT differentiation of
sebocytes resumed. Two markers of SG stem cells have been
described: the EGFR antagonist Lrig1 and the transcriptional co-
repressor Blimp1. Blimp1 is not reported to be expressed in the region
where new follicles originated (Horsley et al., 2006). However, Lrig1 is
expressed by multi-potent, Lgr6-positive stem cells in the junctional
zone (Jensen et al., 2009; Snippert et al., 2010) and these cells are
known to expand on β-catenin activation (Jensen et al., 2009). 4OHT
treatment of ΔK5ΔNβ-cateninER transgenics resulted in increased
Lrig1 expression (Fig. 8F), which could either reﬂect expansion of the
stem cell compartment or Myc-dependent upregulation as a result of
increased proliferation (Fig. 6C; Jensen et al., 2009). Further analysis is
required to determine whether the β-catenin responsive cells at the
base of the SG are a new stem cell population or whether there are
unique characteristics of their location that are permissive to ectopic
follicle formation.
Treatment with a 1,25-dihydroxyvitamin D3 analogue did not
over-ride the block in ectopic follicle formation of bulge stem cells, but
enhanced differentiation of SG-derived hair follicles. This is consistent
with the observation that epidermal cells that lack the VDR exhibit
increased sebocyte differentiation (Cianferotti et al., 2007; Luderer
and Demay, 2010). The 1,25-dihydroxyvitamin D3 analogue stimu-
lated ectopic follicle formation in the ORS below the bulge and also in
the HF bulb, which is in good agreement with the observation that
1,25-dihydroxyvitamin D3 enhances HF differentiation when active
β-catenin is expressed throughout the basal layer of the epidermis
(Pálmer et al., 2008a). The recent ﬁnding that CDP is a ligand-
dependent co-activator of the VDR (Ochiai et al., 2009) suggests that
CDP may play a positive role in hair follicle formation that has not
been appreciated previously. One effect of 1,25-dihydroxyvitamin D3
may be to promote downward growth of ectopic follicles, since VDR
null keratinocytes exhibit defective motility (Pálmer et al., 2008b).
One ﬁnal issue is the relationship between β-catenin activation
and tumour formation. Sustained β-catenin activity drives the
formation of benign HF tumours called pilomatricomas in mouse
models (Gat et al., 1998; Lo Celso et al., 2004) and the equivalent
human tumours have activating β-catenin mutations (Chan et al.,
1999). Lineage tracing shows that cells from the bulge can contribute
to squamous cell carcinomas, and ablation of β-catenin via the K14
promoter results in regression of chemically induced papillomas
(Malanchi et al., 2008). The lack of tumours in the K15ΔNβ-cateninER
mice indicates that activation of β-catenin exclusively in the bulge is
not sufﬁcient to cause pilomatricomas, whether in undamaged tissue
50 C.M. Baker et al. / Developmental Biology 343 (2010) 40–50(Fig. 5) or following wounding (data not shown). Prolonged activation
of β-catenin under the control of the ΔK5 promoter led to massive
growth of hair follicle cells, but the phenotype was not as severe as in
K14ΔNβ-cateninER mice (Lo Celso et al., 2004). This may indicate a
contribution of IFE or junctional zone cells to tumour formation.
Taken togetherwithprevious observations (Silva-Vargaset al., 2005;
Jensen et al., 2009), our results indicate that the SG, junctional zone and
interfollicular epidermis are competent to form ectopic hair follicles in
response to β-catenin activation, whereas the bulge is not. Responsive-
ness toWnt signalling thereforedependsnot only on signal strengthand
duration (Lo Celso et al., 2004; Lowry et al., 2005; Silva-Vargas et al.,
2005) but also on the status or location of the responding cells.
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